Shared Facilities

As genomics experts and through sustainable partnerships we offer technological expertise and consultancy to accelerate the understanding and use of microorganisms.

CHDR has more than 30 years of experience in performing early-phase drug studies. We perform around 60 early-phase clinical studies per year in both healthy volunteers and patients, of which 15 are first-in-human studies.